Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels and reduces glucagon levels in type 2 diabetes. - Ahren,B.; Landin-Olsson,M.; Jansson,P-A. (J Clin Endocrinol Metab, 2004)